About Us

Olympus was established in October 12, 1919.
1919
Established
October 12
Milestones

Fiscal year ended March 2021: Consolidated revenue 730.5 billion Yen.
￥730.5bn
Consolidated Revenue
FY2021
Company Outline

Fiscal year ended March 2021: Total Medical Revenue 625.5 billion Yen.
￥625.5bn
Total Medical Revenue
FY2021
Medical Business

Olympus is the leader in gastrointestinal endoscopic equipment. our global market share is about 70%
70％
Global Market Share*
*As of November 2020
Facts & Figures

Message from the President
As we mark our 100th anniversary this year, we are beginning in earnest to transform Olympus into a more powerful and agile company for sustainable growth.
Corporate Philosophy and Management Policy
Company Profile
Corporate Governance
Worldwide Office Locations
Milestones
Olympus Connects with Society
Company Presentation
The latest Company Presentation download

News

Jun. 01, 2021 CorporateOlympus Agrees on Transfer of its IT Solutions Subsidiary Company
May. 28, 2021 CorporateOlympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
May. 06, 2021 CorporateOlympus Targets Carbon Neutrality by 2030
Apr. 08, 2021 CorporateOlympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business
Mar. 23, 2021 CorporateOlympus completes transfer of its regenerative medicine business Olympus RMS to Rohto Pharmaceutical

View All

Online Inquiry Form

Contact Olympus Japan
Contact your local Olympus office